LifeStyle

• 
  LG Chem leads project to recover resource in cement production SEOUL -- South Korean cement companies are expanding the use of waste plastic with high bio-mass content as an alternative fuel to reduce greenhouse gas emissions from the heating of limestone, the burning of fossil fuels, and a chemical process called calcination. Burning waste plastics produces chlorine dust, a byproduct that cannot be recycled. Chlorine components attached to the walls of cement preheaters also reduce the utilization of production facilities. LG Chem tied up wit 2022-06-30
• 
  S. Korea's first homemade COVID-19 vaccine secures final state approval for manufacturing and sales SEOUL -- South Korea's first homemade COVID-19 vaccine developed by SK Bioscience secured final state approval for manufacturing and sales at home and abroad. SK Bioscience will seek to get its vaccine listed by the World Health Organization for emergency use. The Ministry of Food and Drug Safety, a government public health agency, said it has approved the manufacturing and sales of SK Bioscience's vaccine codenamed GBP510 as a condition of submitting the final result repor 2022-06-29
• 
  Silica used for Kolmar Korea's color cosmetics to replace microplastics SEOUL -- Powder formulations containing microplastics are widely used for the soft application of color cosmetics, but research has been conducted to find alternative materials as microscopic plastic particles have become a serious environmental issue that can have devastating effects on ecosystems and human health. Kolmar Korea, a beauty and cosmetics product maker, has developed a technology that replaces microplastics used in color cosmetics with silica, a natural substance Silic 2022-06-29
• 
  CGBIO leads state-funded project to develop new negative pressure wound treatment device SEOUL -- CGBIO, a total healthcare provider in South Korea, has been selected for a state-funded project to develop a new negative pressure wound cleaning and healing device that can regenerate wounds and treat infections at the same time. The project is aimed at enhancing the competitiveness of localized equipment in the global market dominated by foreign companies. Negative pressure wound therapy (NPWT) improves the healing of open nonsurgical wounds using negative pressure for th 2022-06-27
• 
  Researchers propose practical solution to prevent cross-infection while preserving skin naturalness SEOUL -- A COVID-19 pandemic has called for the enhanced hygiene of public facilities. The fear of infection prompted the fast adoption of antibacterial materials such as gloves. Antibacterial films and similar materials were widely used to cover elevator buttons, door handles and other objects that are frequently touched by many random people. However, there has been no practical solution to prevent cross-infection while preserving intrinsic skin naturalness. South Korean and Jap 2022-06-23
• 
  Theragen Bio selected for state project to produce new chips for genomic analysis SEOUL -- Theragen Bio, a genetic analysis service provider, has been selected for a state project to produce advanced chips for genomic analysis that would be used for identifying the genetic causes of common chronic diseases among Korean people. The Korea Disease Control and Prevention Agency (KDCA), a state health body, has launched a "Korean Chip" project to identify the genetic causes of common chronic diseases by collecting information on genetic variation. A genome 2022-06-07
• 
  Yuhan works with research teams to develop new drug platforms based on mRNA SEOUL -- Yuhan, a pharmaceutical and chemical company in South Korea, will push for the development of new drug platform technologies based on messenger ribonucleic acid (mRNA) in cooperation with U.S. and South Koran university research teams. mRNA is a transient intermediator between genes and proteins. It has emerged as a new category of therapeutic agent to prevent and treat various diseases. To function in vivo, mRNA requires safe, effective and stable delivery systems such as 2022-06-07
• 
  State project launched to develop biodegradable marine bioplastic materials using seaweed SEOUL -- South Korea has launched a state project to develop biodegradable marine bioplastic materials using seaweed such as sargassum horneri, a species of brown macroalgae called "devil weed" from China that is detrimental to a foreshore ecosystem and damages sea farms almost every year. Since bioplastics mainly use grain biomass such as corn as raw materials, their production is still insignificant due to economic problems caused by expensive raw materials. The Minis 2022-06-07
• 
  Protected marine creature bred artificially for discharge in river habitat SEOUL -- Clithon retropictum is a protected species of freshwater and brackish water snail with an operculum. It lives in the estuary of a clean river and eats attached algae or organic matter. It is very vulnerable to the deterioration of water quality or changes in the river environment. The Ministry of Oceans and Fisheries designated the bracken as a protected marine creature in 2016 and succeeded in developing artificial proliferation in 2021 for the first time in the world in 2022-06-02
• 
  HK inno.N ties up with domestic company to find new drug candidates using exosome SEOUL -- HK inno.N, a pharmaceutical product maker in South Korea, will find new drug candidates using exosomes for the treatment of chronic diseases and acute respiratory infections in cooperation with a domestic biotechnology company that specializes in therapeutic molecules. Exosomes, which are recognized for their critical role in cell-to-cell communication and transportation, are small vesicles found in nearly all eukaryotic fluids and facilitate a variety of important cellula 2022-05-27
• 
  SK Bioscience delivers first shipment of chickenpox vaccine to Latin America SEOUL -- SK Bioscience has delivered the first shipment of its chickenpox vaccine injection solution, Sky Varicella, as part of a $31.27 million order from an international public health agency that regularly identifies the provisional demand for chickenpox vaccines from member countries in Latin America. Through preliminary bidding, the Pan American Health Organization (PAHO) selects companies with global technology and productivity as chickenpox vaccine providers. SK Bioscience s 2022-05-23
• 
  University team applies genetic tracking system to breed 'low-carbon' cow SEOUL -- Fertilizing feed for beef cattle produces nitrous oxide emissions, a powerful greenhouse gas produced by microbes. Cows burp out large quantities of heat-trapping methane. As a result, beef causes vastly more emissions than most other foods. Various solutions have been studied to lower the carbon footprint of beef and dairy cattle. A research team led by Lee Hak-gyo, a professor of animal life engineering at Jeonbuk National University has acquired a method to distinguish & 2022-05-23
• 
  Axiom founder holds business talks with Boryung's CEO as partners in space project SEOUL -- Kam Ghaffarian, the founder of U.S. space infrastructure developer Axiom Space, has held business talks with Boryung Corp.'s leader during his visit to South Korea as a partner in their joint initiative to advance the next generation of pharmaceutical, bioscience and medtech development in space. The meeting with CEO Jay Kim of Boryung Corp. engaged in pharmaceutical manufacturing, took place on May 17 in Seoul. Boryung has made an unspecified amount of equity investmen 2022-05-19
• 
  Researchers work on alginate mass production to reduce S. Korea's reliance on imports SEOUL -- In an effort to reduce South Korea's heavy reliance on imports, a state marine research body in South Korea will lead a government project to develop technologies for the mass production of alginate, an anionic polymer that occurs naturally in brown algae. Alginates are used as a pharmaceutical or biomedical ingredient or as a compound for advanced biotechnology. Alginic acid is hydrophilic and forms a viscous gum when hydrated. With metals such as sodium and calcium, 2022-05-12
• 
  GI Innovation's GI-101 selected for government-initiated drug development program SEOUL -- GI-101, an immunotherapy agent being developed by South Korea's bio-venture company GI Innovation, has been selected for a government-initiated drug development program to receive financial support at clinical stages. GI Innovation said it would get up to seven billion won ($5.5 million) in research support for two years from the Korea Drug Development Fund (KDDF), which supports the investment, nurture and development of promising drugs. KDDF's move is seen as a 2022-05-09
• 
  Yanolja's cloud solution wing makes strategic investment in India's Innkey SEOUL -- The cloud solution wing of Yanolja, a leading travel and leisure activity reservation service platform in South Korea, will make a strategic investment in Innkey Infosystems with the conditional acquisition of the India-based service provider of cloud-based hotel management software. Yanolja Cloud said the investment is aimed at expanding its global Software-as-a-Service (Saas) solution business by combining the technology and know-how of the two companies. Innkey provide 2022-05-04
• 
  Rare ordinance enacted by local assemblymen to protect toad ecosystem SEOUL -- A rare ordinance has been enacted by local assemblymen in South Korea to protect an ecosystem for the Asiatic toad between their habitat in a mountain and a spawning ground in the middle of a residential area. The Asiatic toad is a species of toad endemic to East Asia. The species is relatively rare on the Korean Peninsula. The Asiatic toad avoids dense forests, but is found in most other habitats, including grasslands, open forests, meadows, and cultivated areas. It pref 2022-04-26
• 
  World's first prototype floating community in Busan designed to accommodate residents living on ideal eco-village SEOUL -- The world's first prototype of a floating community to be built in South Korea's southern port city of Busan for a United Nations project to present a solution to ensure climate resilience will be designed to accommodate thousands of residents living on an ideal eco-village where water leisure and daily life harmonize. As the world's coastal cities are increasingly threatened by rising populations and sea levels, the UN is exploring a new approach to building 2022-04-26
• 
  SK Bioscience's COVID-19 vaccine acquires successful results in final-stage clinical trial SEOUL -- Based on successful results in final-stage clinical trials at home and abroad, SK Bioscience will seek to apply for state approval to commercialize its COVID-19 vaccine candidate codenamed GBP510 after securing data on its safety by the end of April. SK Bioscience said that GBP510 has produced successful results in phase 3 clinical trials involving 4,037 adults aged 18 or older in South Korea, Thailand, Vietnam, New Zealand, Ukraine, and the Philippines, such as showing e 2022-04-25
• 
  Daewoong applies for state approval to use Nabota botox for masseteric hypertrophy SEOUL -- Daewoong Pharmaceutical, a bioengineering company in South Korea, has applied for state approval to use Nabota, a botulinum toxin product developed for the treatment of frown lines, as the treatment of benign masseteric hypertrophy (square jaw) based on the positive results of a final clinical study. Benign masseteric hypertrophy is a relatively uncommon condition that can occur unilaterally or bilaterally. Unilateral- or bilateral hypertrophy of the masseter muscle is c 2022-04-21